Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chubb
Daiichi Sankyo
Covington
Farmers Insurance
AstraZeneca
Boehringer Ingelheim
Cantor Fitzgerald
Express Scripts
Merck

Generated: October 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,360,817

« Back to Dashboard

Summary for Patent: 5,360,817

Title: Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid and their use as antiviral agents
Abstract:Derivatives and analogues of 2-deoxy-2,3-didehydro-N-acetyl neuraminic acid, pharmaceutical formulations thereof, methods for their preparation .and their use in the treatment of viral infections, in particular influenza, are described.
Inventor(s): von Izstein; Laurence M. (North Fitzray, AU), Wu; Wen-Yang (Mount Waverley, AU), Phan; Tho V. (Carnegie, AU), Danylec; Basil (Box Hill, AU), Jin; Betty (Mount Waverley, AU)
Assignee: Biota Scientific Management Pty Ltd (Melbourne, AU)
Application Number:07/946,327
Patent Claim Types:
see list of patent claims
Compound; Composition; Formulation;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,360,817

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
AustraliaPJ9800Apr 24, 1990
AustraliaPK2896Oct 19, 1990
AustraliaPK4537Feb 11, 1991
PCT Information
PCT FiledApril 24, 1991PCT Application Number:PCT/AU91/00161
PCT Publication Date:October 31, 1991PCT Publication Number: WO91/16320

International Patent Family for Patent: 5,360,817

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark0526543► Subscribe
Germany69133604► Subscribe
Germany69128469► Subscribe
Germany19975068► Subscribe
Cyprus2186► Subscribe
Czech Republic288492► Subscribe
Czechoslovakia9101145► Subscribe
China1143853► Subscribe
China1184108► Subscribe
China1091594► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Teva
QuintilesIMS
Harvard Business School
Baxter
Johnson and Johnson
Healthtrust
Merck
AstraZeneca
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot